Variable | Disease-free survival | Overall survival | ||||||||||
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||||||
HR | 95% CI | P values | HR | 95% CI | P values | HR | 95% CI | P values | HR | 95% CI | P values | |
Age, years (≤60 vs >61) | 0.58 | 0.38 to 0.84 | 0.04 | 0.58 | 0.34 to 0.97 | 0.005 | 0.76 | 0.48 to 1.21 | 0.25 | |||
Type of surgery (LT vs LS) | 0.72 | 0.37 to 1.37 | 0.32 | 0.71 | 0.33 to 1.55 | 0.25 | ||||||
Grade (1 vs 3) | 0.65 | 0.36 to 1.16 | 0.16 | 0.89 | 0.46 to 1.73 | 0.644 | ||||||
Grade (2 vs 3) | 0.70 | 0.47 to 1.06 | 0.78 | 0.47 to 1.30 | ||||||||
Lymphovascular space invasion (negative vs positive) | 0.57 | 0.36 to 0.90 | 0.02 | 0.71 | 0.38 to 1.30 | 0.34 | 0.54 | 0.30 to 0.97 | 0.04 | 0.73 | 0.37 to 1.43 | 0.37 |
Peritoneal cytology (negative vs positive) | 0.83 | 0.48 to 1.42 | 0.49 | 0.55 | 0.30 to 1.01 | 0.05 | 0.45 | 0.23 to 0.86 | 0.02 | |||
Myometrial invasion (<50% vs >50%) | 0.51 | 0.31 to 0.83 | 0.007 | 0.57 | 0.29 to 1.14 | 0.13 | 0.45 | 0.23 to 0.85 | 0.01 | 0.50 | 0.21 to 1.03 | 0.09 |
Cervical involvement (no vs yes) | 0.65 | 0.44 to 0.95 | 0.02 | 1.01 | 0.59 to 1.73 | 0.94 | 0.50 | 0.31 to 0.80 | 0.004 | 0.94 | 0.49 to 1.71 | 0.79 |
Lymphadenectomy (yes vs no) | 0.81 | 0.41 to 1.37 | 0.09 | 0.52 | 0.30 to 0.91 | 0.007 | 0.33 | 0.16 to 0.77 | 0.001 | |||
Adjuvant therapy | 0.12 | 0.48 | ||||||||||
Radiotherapy vs chemoradiation | 1.18 | 0.74 to 1.89 | 1.35 | 0.79 to 2.32 | ||||||||
Chemotherapy vs chemoradiation | 1.64 | 1.02 to 2.64 | 1.30 | 0.71 to 2.38 |
LS, laparoscopy; LT, laparotomy.